vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and NexPoint Real Estate Finance, Inc. (NREF). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $11.1M, roughly 1.7× NexPoint Real Estate Finance, Inc.). NexPoint Real Estate Finance, Inc. runs the higher net margin — 216.6% vs -6.8%, a 223.4% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -48.8%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.
APYX vs NREF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $11.1M |
| Net Profit | $-1.3M | $24.0M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | — |
| Net Margin | -6.8% | 216.6% |
| Revenue YoY | 34.7% | -48.8% |
| Net Profit YoY | 71.9% | 58.7% |
| EPS (diluted) | — | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $11.1M | ||
| Q3 25 | $12.9M | $12.5M | ||
| Q2 25 | $11.4M | $12.1M | ||
| Q1 25 | $9.4M | $11.5M | ||
| Q4 24 | $14.2M | $21.7M | ||
| Q3 24 | $11.5M | $12.5M | ||
| Q2 24 | $12.1M | $6.7M | ||
| Q1 24 | $10.2M | $-12.8M |
| Q4 25 | $-1.3M | $24.0M | ||
| Q3 25 | $-2.0M | $50.9M | ||
| Q2 25 | $-3.8M | $22.3M | ||
| Q1 25 | $-4.2M | $26.0M | ||
| Q4 24 | $-4.6M | $15.2M | ||
| Q3 24 | $-4.7M | $23.3M | ||
| Q2 24 | $-6.6M | $12.1M | ||
| Q1 24 | $-7.6M | $-14.6M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | -6.5% | — | ||
| Q2 25 | -22.6% | — | ||
| Q1 25 | -32.4% | — | ||
| Q4 24 | -21.4% | — | ||
| Q3 24 | -31.6% | — | ||
| Q2 24 | -45.7% | — | ||
| Q1 24 | -64.6% | — |
| Q4 25 | -6.8% | 216.6% | ||
| Q3 25 | -15.4% | 407.0% | ||
| Q2 25 | -33.2% | 184.5% | ||
| Q1 25 | -44.0% | 225.6% | ||
| Q4 24 | -32.5% | 69.9% | ||
| Q3 24 | -40.9% | 186.4% | ||
| Q2 24 | -54.0% | 179.7% | ||
| Q1 24 | -74.0% | 114.3% |
| Q4 25 | — | $0.47 | ||
| Q3 25 | — | $1.14 | ||
| Q2 25 | — | $0.54 | ||
| Q1 25 | — | $0.70 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | $-0.19 | $0.40 | ||
| Q1 24 | $-0.22 | $-0.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $31.1M |
| Total DebtLower is stronger | $37.5M | $771.2M |
| Stockholders' EquityBook value | $14.5M | $388.0M |
| Total Assets | $66.8M | $5.3B |
| Debt / EquityLower = less leverage | 2.58× | 1.99× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $31.1M | ||
| Q3 25 | $25.1M | $17.9M | ||
| Q2 25 | $29.3M | $9.1M | ||
| Q1 25 | $31.0M | $19.2M | ||
| Q4 24 | $31.7M | $3.9M | ||
| Q3 24 | $28.0M | $34.7M | ||
| Q2 24 | $32.7M | $4.3M | ||
| Q1 24 | $37.3M | $13.5M |
| Q4 25 | $37.5M | $771.2M | ||
| Q3 25 | $37.5M | $720.9M | ||
| Q2 25 | $37.5M | $815.6M | ||
| Q1 25 | $37.5M | $831.5M | ||
| Q4 24 | $37.5M | $799.3M | ||
| Q3 24 | $37.5M | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
| Q4 25 | $14.5M | $388.0M | ||
| Q3 25 | $5.8M | $375.4M | ||
| Q2 25 | $7.3M | $348.2M | ||
| Q1 25 | $10.5M | $343.7M | ||
| Q4 24 | $14.2M | $336.5M | ||
| Q3 24 | $11.0M | $335.8M | ||
| Q2 24 | $14.7M | $327.5M | ||
| Q1 24 | $20.3M | $327.1M |
| Q4 25 | $66.8M | $5.3B | ||
| Q3 25 | $57.4M | $5.3B | ||
| Q2 25 | $58.2M | $5.4B | ||
| Q1 25 | $60.2M | $5.4B | ||
| Q4 24 | $64.8M | $5.4B | ||
| Q3 24 | $60.7M | $5.7B | ||
| Q2 24 | $65.4M | $6.6B | ||
| Q1 24 | $70.7M | $7.1B |
| Q4 25 | 2.58× | 1.99× | ||
| Q3 25 | 6.41× | 1.92× | ||
| Q2 25 | 5.17× | 2.34× | ||
| Q1 25 | 3.57× | 2.42× | ||
| Q4 24 | 2.64× | 2.38× | ||
| Q3 24 | 3.40× | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-4.5M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-4.5M | ||
| Q3 25 | $-3.5M | $8.1M | ||
| Q2 25 | $-1.2M | $3.3M | ||
| Q1 25 | $-702.0K | $16.0M | ||
| Q4 24 | $-2.9M | $4.4M | ||
| Q3 24 | $-4.4M | $14.7M | ||
| Q2 24 | $-4.3M | $-7.5M | ||
| Q1 24 | $-6.3M | $17.7M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
